Get Your Personalized Supplement StackSupplement Stack Quiz

Cnidium Extract

Also known as: Cnidium, She Chuang Zi, C. monnieri, C. officinale, Cnidium monnieri

Overview

Cnidium monnieri is a medicinal plant native to China and parts of Asia, traditionally used in Chinese medicine for its health-promoting properties. The fruit and roots of the plant contain bioactive compounds such as imperatorin and osthole, known for their potential anti-inflammatory, antiviral, and vasodilatory effects. Research is particularly focused on its role in managing hypertension and erectile dysfunction. While the interest in Cnidium's pharmacological benefits has grown, the evidence remains primarily from animal studies, necessitating comprehensive clinical trials in humans to confirm these effects and establish safe usage guidelines.

Benefits

Evidence suggests that Cnidium monnieri may exert vasorelaxant effects, contributing to lower blood pressure in animal models, particularly in hypertensive rats treated with 50% ethanol extract. While traditional uses propose additional anti-inflammatory and antiviral benefits, these have not been thoroughly validated by clinical research. Notably, reliance on animal studies highlights the urgent need for well-designed human trials to substantiate the health benefits of Cnidium. However, there is preliminary support for its potential role in hypertension management, warranting further investigation in clinical settings.

How it works

Cnidium monnieri operates primarily by inhibiting calcium influx across cell membranes through receptor-operated calcium channels (ROCCs) and voltage-dependent calcium channels (VDCCs). This mechanism leads to vasorelaxation, helping lower blood pressure. Notably, the active components imperatorin and osthole function independently of the nitric oxide/cyclic guanosine monophosphate signaling pathway, providing a distinct response mechanism that enhances vascular relaxation and may support cardiovascular health.

Side effects

The safety profile of Cnidium monnieri remains largely undefined due to a lack of extensive human studies. While animal research suggests it is generally well tolerated, specific adverse effects in humans with notable prevalence (over 5%) have not been documented. Caution is advised regarding potential drug interactions, particularly with medications affecting blood pressure and calcium channels. Furthermore, contraindications have not been well established, and its safety in vulnerable groups, including pregnant individuals, is unclear. Until more definitive safety data arises, a cautious approach to its use is recommended.

Dosage

Currently, there are no standardized dosage guidelines for Cnidium monnieri in humans. Based on animal studies, a minimum effective dose is estimated to be between 10-30 μg/mL of the active constituents; however, optimal or maximum safe dosages have yet to be determined. The 50% ethanol extract is commonly studied, but the factors affecting its absorption, such as interactions with food, remain largely unexplored. Further research is critical to formulate appropriate dosage recommendations for clinical use.